
Adipogen/Telithromycin/BVT-0456-M001/1 mg
商品编号:
BVT-0456-M001
品牌:
Adipogen Inc
市场价:
¥1600.00
美元价:
960.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | RU66647;Ketek;HMR3647 |
ProductType | Chemical |
Properties | |
Formula | C43H65N5O10 |
MW | 812.0 |
CAS | 191114-48-4 |
RTECS | HB7878000 |
Source/HostChemicals | Semi-synthetic. |
PurityChemicals | ≥98%(NMR,TLC) |
Appearance | Whitesolid. |
Solubility | SolubleinDMSO,ethanol,methanol,acetoneormethylenechloride.Sparinglysolubleinwater(0.3mg/ml). |
Identity | Determinedby1H-NMR. |
Declaration | ManufacturedbyBioViotica. |
InChiKey | LJVAJPDWBABPEJ-XLSPMWLOSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
HandlingAdvice | Protectfromlightwheninsolution. |
Use/StABIlity | Stableforatleast1yearafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- Ketolidetypemacrolideantibiotic.
- Antibacterialcompoundusedtotreatmildtomoderaterespiratoryinfections.
- Proteinsynthesisinhibitor,bybindingtothe50Sribosomalsubunitandsubsequentlyblockingtheprogressionofthegrowingpolypeptidechain.BindstodomainsIIandVofthe23SrRNAofthe50Sribosomalsubunit.
- HasahigheraffinityfortheseribosomaltargetsthanconventionalmacrolidesduetotheadditionalinteractionsandincreasedbindingatdomainII.RetainsactivityagainstGram-positivecocciinthepresenceofresistancemediatedbymethylases(ermgenes)thatalterthebindingsiteatdomainV.
- Mayinhibittheformationofribosomalsubunits50Sand30S.
ProductReferences
- TheketolideantibioticsHMR-3647andHMR3004areactiveagainstToxoplasmagondiiinvitroandinmurinemodelsofinfection:F.G.Araujo,etal.;Antimicrob.AgentsChemother.41,2137(1997)
- Thein-vitroactivityofHMR3647,anewketolideantimicrobialagent:F.J.Boswell,etal.;J.Antimicrob.Chemother.42,703(1998)
- Drugsofthe21stcentury:telithromycin(HMR3647)-thefirstketolide:G.Ackermann&A.C.Rodloff;J.Antimicrob.Chemother.51,497(2003)
- Telithromycin:K.Wellington&S.Noble;Drugs64,1683(2004)
- Telithromycin:Aketolideantibioticfortreatmentofrespiratorytractinfections:J.R.Lonks&D.A.Goldmann;Clin.Inf.Dis.40,1657(2005)
- Antibacterialdrugdiscovery-Then,nowandthegenomicsfuture:R.Monaghan&J.F.Barrett;Biochem.Pharmacol.71,901(2006)
- Telithromycininthetreatmentofpneumococcalcommunity-acquiredrespiratorytractinfections:areview:C.M.Fogarty,etal.;Int.J.Infect.Dis.10,136(2006)
- Benefit-riskassessmentoftelithromycininthetreatmentofcommunity-acquiredpneumonia:S.D.Brown;DrugSafety31,561(2008)
- Time-dependenteffectsofKlebsiellapneumoniaendotoxinonthetelithromycinpharmacokineticsinrats;restorationoftheparametersin96-hourKPLPSratstothecontrollevels:J.H.Lee,etal.;Pulm.Pharmacol.Ther.21,860(2008)
- Ketolides-themodernrelativesofmacrolides:thepharmacokineticperspective:M.Zeitlinger,etal.;Clin.Pharmacokinet.48,23(2009)
- InducIBLeexpressionoferm(B)bytheketolidestelithromycinandcethromycin:P.Byoungduck&M.Yu-Hong;Int.J.Antimicrob.Agents46,226(2015)
- ClpP-independentfunctionofClpXinterfereswithtelithromycinresistanceconferredbymsr(A)inStaphylococcusaureus:V.Vimberg,etal.;Antimicrob.AgentsChemother.59,3611(2015)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们